Showing 1491-1500 of 2050 results for "".
- J&J Vision Introduces Artificial-Intelligence Powered Virtual Assistant for Contact Lenseshttps://modernod.com/news/jj-vision-introduces-artificial-intelligence-powered-virtual-assistant-for-contact-lenses/2480195/Johnson & Johnson Vision introduced Andy, a virtual assistant chatbot powered by artificial intelligence (AI). Andy is designed to help guide U.S. consumers throughout their Acuvue brand contact lens journey – from those considering contact lenses for the first time to long-term wearers. The
- Blanchard Announces Notching Technology for the Onefit Family of Scleral Lenses: Control Peripheral Recesshttps://modernod.com/news/blanchard-announces-notching-technology-for-the-onefit-family-of-scleral-lenses-control-peripheral-recess/2480206/Blanchard Contact Lenses has unveiled their latest design option for its Onefit and Onefit MED scleral lenses. Control Peripheral Recess (CPR) is a manufacturing process that creates
- CheckedUp Announces Content Licensing Initiative with The American Academy of Ophthalmology to Strengthen its Patient Education Offeringshttps://modernod.com/news/checkedup-announces-content-licensing-initiative-with-the-american-academy-of-ophthalmology-to-strengthen-its-patient-education-offerings/2480213/CheckedUp announced that it has singed a content licensing agreement with the American Academy of Ophthalmology (AAO) in which CheckedUp will provide professional programming produced by AAO on its waiting room and exam room technology platforms. “Our membership has continued its unprecede
- Congressional Briefing Discussing Safety of Contact Lenses as Regulated Medical Devices to be Held Tomorrowhttps://modernod.com/news/congressional-briefing-discussing-safety-of-contact-lenses-as-regulated-medical-devices-to-be-held-tomorrow/2480218/The Health Care Alliance for Patient Safety will hold a congressional briefing tomorrow, Tuesday, April 24, 2018, from noon-1 pm in The Rayburn House Office Building, Room 2247, in Washington DC, to discuss the importance of protecting the safety of patients who use contact lenses, which are regu
- Johnson & Johnson Vision Introduces Contact Lens with Transitions Light Intelligent Technologyhttps://modernod.com/news/johnson-johnson-vision-announces-contact-lens-innovation-with-acuvue-oasys-with-transitions-light-intelligent-technology/2480264/Johnson & Johnson Vision has introduced the Acuvue Oasys with Transitions Light Intelligent Technology, a first-of-its-kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the eye, acco
- Vabysmo Showed Extended Durability, Continued Efficacy and a Consistent Safety Profile in Long-Term DME Studyhttps://modernod.com/news/vabysmo-showed-extended-durability-continued-efficacy-and-a-consistent-safety-profile-in-long-term-dme-study/2482363/At the American Society of Retina Specialists (ASRS) 2024 Annual Meeting in Stockholm, Sweden, Genentech announced new, 4-year data from the RHONE-X extension study. The study met all primary endpoints, showing that Vabysmo (faricimab-svoa) was well tolerated in people with diabetic mac
- Harrow Enters into 340B Prime Vendor Program Contract with Apexus for Iheezohttps://modernod.com/news/harrow-enters-into-340b-prime-vendor-program-contract-with-apexus-for-iheezo/2482349/Harrow announced that as of July 1, 2024, it has entered into an agreement with Apexus to make Iheezo (chloroprocaine hydrochloride ophthalmic gel) 3% and other Harrow products available through its 340B Prime Vendor Program. Iheezo, indicated for ocular anesthesia, is a low-visc
- FDA Warns Consumers of Contaminated Copycat Versions of Lumify Eye Dropshttps://modernod.com/news/fda-warns-consumers-of-contaminated-copycat-versions-of-lumify-eye-drops/2482094/FDA is warning consumers not to purchase or use South Moon, Rebright, or FivFivGo eye drops because of the potential risk of eye infection. These are copycat eye drops that consumers can easily mistake for Bausch + Lomb’s Lumify brand eye drops, an over-the-counter product approved for
- NIH: New Technique Enhances Quality Control of Lab-Grown Cells for AMD Treatmenthttps://modernod.com/news/nih-new-technique-enhances-quality-control-of-lab-grown-cells-for-amd-treatment/2482074/Researchers at the National Eye Institute (NEI) say they have improved a crucial step in the production of retinal pigment epithelium (RPE) they are testing in a clinical trial as treatment for age-related macular degeneration (AMD). Their technique combines electrochemical cell measurements
- iSTAR Medical Continues European Expansion with First MINIject Surgeries in the Netherlandshttps://modernod.com/news/istar-medical-continues-european-expansion-with-first-miniject-surgeries-in-the-netherlands/2482027/iSTAR Medical announced the successful first implantations of MINIject, the company’s bio-integrating, minimally-invasive glaucoma surgery (MIGS) device, in the Netherlands. Patients were successfully implanted at the University Eye Clinic of the Maastricht University Medical Center+ b